The study presented by Dr. Ioanna Kalograiaki during the advanced course of the FEBS (Federation of European Biochemical Societies) Matrix Pathology, Signaling and Molecular Targets, has been awarded the best presentation.

This study is part of the RETOS COLABORACION project (MINECO, Spain) in which INMUNOTEK participates, together with the Biological Research Center, the Complutense University and the Clinico San Carlos Hospital of Madrid, for the development of a  cancer vaccine based on the tumor carbohydrate Ca10.

---